Skip to content

March 22, 2024

The Highest Rated VA Disabilities Explained!

I hope you enjoy reading this blog post.

If you want to learn how to implement these strategies to get the VA benefits you deserve, click here to speak with a VA claim expert for free.


Looking for Expert-Level VA Claim Help?📱Call Us Now! 737-295-2226

Today, Brian Reese the VA Claims Insider reveals and explains the highest rated VA disabilities.

This detailed list of the highest rated VA disability claims is broken down into body system/part, disability name, and the rating criteria to get a 100 percent VA rating.

Okay, without further ado, let’s begin!

You Might Also Like These Blog Posts

Top 10 (Most Common) Highest Rated VA Disability Claims

Top 10 Highest Rated VA Disability Claims

Here’s a list of the 10 highest rated VA claims that can be rated at 100% with the most severe symptoms:

  • Mental health conditions
  • Chronic fatigue syndrome (CFS)
  • Meniere’s syndrome (endolymphatic hydrops)
  • Cancer (not in remission)
  • Severe back and spine conditions
  • Severe asthma
  • Diabetes mellitus
  • Heart disease
  • Kidney disease
  • Amputations

What are the Highest Rated VA Disabilities?

Here’s a detailed list of 279 VA disabilities that can be rated up to 100 percent, along with the criteria needed to get the highest scheduler rating by law.

We also recommend reviewing CFR Title 38, Part 4, the Schedule for Rating Disabilities for each condition.

Body System/PartDisability NameCriteria for a 100% VA Rating
MusculoskeletalOsteomyelitis, acute, subacute, or chronicOf the pelvis, vertebrae, or extending into major joints, or with multiple localization or with long history of intractability and debility, anemia, amyloid liver changes, or other continuous constitutional symptoms
Bones and joints, tuberculosis of, active or inactiveIf Inactive:
Tuberculosis in effect on August 19,1968 – 2 years after date of inactivity, following active tuberculosis, which was clinically identified during service or subsequently
Tuberculosis in effect after August 19, 1968 – 1 year after date of inactivity, following active tuberculosis
Multi-joint arthritis (except post-traumatic and gout), 2 or more joints, as an active processWith constitutional manifestations associated with active joint involvement, totally incapacitating
Bones, neoplasm, malignant, primary or secondaryFor 1 year following the cessation of surgical, X-ray, antineoplastic chemotherapy or other prescribed therapeutic procedure.
Shoulder replacement (prosthesis)For 1 year following implantation of prosthesis
Elbow replacement (prosthesis)For 1 year following implantation of prosthesis
Wrist replacement (prosthesis)For 1 year following implantation of prosthesis
Hip, resurfacing or replacement (prosthesis)For 4 months following implantation of prosthesis or resurfacing
Knee, resurfacing or replacement (prosthesis)For 4 months following implantation of prosthesis or resurfacing
Ankle replacement (prosthesis)For 1 year following implantation of prosthesis
Anatomical loss of one hand and loss of use of one footN/A
Anatomical loss of one foot and loss of use of one handN/A
Anatomical loss of both handsN/A
Anatomical loss of both feetN/A
Anatomical loss of one hand and one footN/A
Loss of use of both handsN/A
Loss of use of both feetN/A
Loss of use of one hand and one footN/A
Complete amputation, upper extremityForequarter amputation (involving complete removal of the humerus along with any portion of the scapula, clavicle, and/or ribs)
Complete amputation, lower extremityTrans-pelvic amputation (involving complete removal of the femur and intrinsic pelvic musculature along with any portion of the pelvic bones)
Vertebral fracture or dislocationUnfavorable ankylosis of the entire spine
Sacroiliac injury and weaknessUnfavorable ankylosis of the entire spine
Lumbosacral or cervical strainUnfavorable ankylosis of the entire spine
Spinal stenosisUnfavorable ankylosis of the entire spine
Spondylolisthesis or segmental instabilityUnfavorable ankylosis of the entire spine
Ankylosing spondylitisUnfavorable ankylosis of the entire spine
Spinal fusionUnfavorable ankylosis of the entire spine
Degenerative arthritis, degenerative disc disease other than intervertebral disc syndromeUnfavorable ankylosis of the entire spine
Intervertebral disc syndromeUnfavorable ankylosis of the entire spine
MuscleSarcoma, soft tissue (of muscle, fat, or fibrous connective tissue)A rating of 100 percent shall continue beyond the cessation of any surgery, radiation treatment, antineoplastic chemotherapy or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination
EyeTuberculosis of eye, active or inactiveIf Inactive:
Tuberculosis in effect on August 19,1968 – 2 years after date of inactivity, following active tuberculosis, which was clinically identified during service or subsequently
Tuberculosis in effect after August 19, 1968 – 1 year after date of inactivity, following active tuberculosis
Malignant neoplasms of the eye, orbit, and adnexa (excluding skin):Requires therapy that is comparable to those used for systemic malignancies. Continue the 100 percent rating beyond the cessation of any surgical, X-ray, antineoplastic chemotherapy, or other therapeutic procedure. Six months after discontinuance of such treatment, the appropriate disability rating will be determined by mandatory VA examination
Anatomical loss of both eyesN/A
No more than light perception in both eyesN/A
Anatomical loss of one eyewith  5/200 (1.5/60) in the other eye
No more than light perception in one eyewith  5/200 (1.5/60) in the other eye
Vision in one eye 5/200 (1.5/60)with  5/200 (1.5/60) in the other eye
Visual field defectsBilateral concentric contraction of visual field
EarMeniere’s syndrome (endolymphatic hydrops)Hearing impairment with attacks of vertigo and cerebellar gait occurring more than once weekly, with or without tinnitus
Malignant neoplasm of the ear (other than skin only)A rating of 100 percent shall continue beyond the cessation of any surgical, radiation treatment, antineoplastic chemotherapy or other therapeutic procedure. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination
Infectious diseases, immune disorders and nutritional deficiencies.Vibriosis (Cholera, Non-cholera)As active disease
Visceral leishmaniasisAs active disease. Continue a 100 percent evaluation beyond the cessation of treatment for active disease. Six months after discontinuance of such treatment, determine the appropriate disability rating by mandatory VA examination.
Leprosy (Hansen’s disease)As active disease. Continue a 100 percent evaluation beyond the cessation of treatment for active disease. Six months after discontinuance of such treatment, determine the appropriate disability rating by mandatory VA examination.
MalariaAs active disease
Lymphatic filariasis, to include elephantiasisAs active disease
BartonellosisAs active disease
PlagueAs active disease
Relapsing FeverAs active disease
Rheumatic feverAs active disease
Tuberculosis, miliary, active or inactiveIf Inactive:
Tuberculosis in effect on August 19,1968 – 2 years after date of inactivity, following active tuberculosis, which was clinically identified during service or subsequently
Tuberculosis in effect after August 19, 1968 – 1 year after date of inactivity, following active tuberculosis
Nontuberculosis mycobacterium infectionAs active disease. Continue the rating of 100 percent for the duration of treatment for active disease followed by a mandatory VA exam.
AvitaminosisMarked mental changes, moist dermatitis, inability to retain adequate nourishment, exhaustion, and cachexia
BeriberiAs active disease. With congestive heart failure, anasarca, or Wernicke-Korsakoff syndrome
PellagraMarked mental changes, moist dermatitis, inability to retain adequate nourishment, exhaustion, and cachexia
BrucellosisAs active disease
Rickettsial, ehrlichia, and anaplasma infectionsAs active disease
MelioidosisAs active disease
Lyme diseaseAs active disease
Parasitic diseases otherwise not specifiedAs active disease
Hyperinfection syndrome or disseminated strongyloidiasisAs active disease. Continue the rating of 100 percent through active disease followed by a mandatory VA exam.
Hemorrhagic fevers, including dengue, yellow fever, and othersAs active disease
Campylobacter jejuni infectionAs active disease
Coxiella burnetii infection (Q fever)As active disease
Nontyphoid salmonella infectionsAs active disease
Shigella infectionsAs active disease
West Nile virus infectionAs active disease
Lupus erythematosus, systemic (disseminated)Not to be combined with ratings under DC 7809 Acute, with frequent exacerbations, producing severe impairment of health
HIV-related illnessAIDS with recurrent opportunistic infections (see Note 3) or with secondary diseases afflicting multiple body systems; HIV-related illness with debility and progressive weight loss
Chronic fatigue syndrome (CFS)Debilitating fatigue, cognitive impairments (such as inability to concentrate, forgetfulness, or confusion), or a combination of other signs and symptoms which are nearly constant and so severe as to restrict routine daily activities almost completely and which may occasionally preclude self-care
RespiratoryLaryngectomy, totalN/A
Aphonia, complete organicConstant inability to communicate by speech
Larynx, stenosis of, including residuals of laryngeal trauma (unilateral or bilateral)Forced expiratory volume in one second (FEV–1) less than 40 percent of predicted value, with Flow-Volume Loop compatible with upper airway obstruction, or; permanent tracheostomy
Granulomatous rhinitisWegener’s granulomatosis, lethal midline granuloma
Bronchitis, chronicFEV–1 less than 40 percent of predicted value, or; the ratio of Forced Expiratory Volume in one second to Forced Vital Capacity (FEV–1/FVC) less than 40 percent, or; Diffusion Capacity of the Lung for Carbon Monoxide by the Single Breath Method (DLCO (SB)) less than 40-percent predicted, or; maximum exercise capacity less than 15 ml/kg/min oxygen consumption (with cardiac or respiratory limitation), or; cor pulmonale (right heart failure), or; right ventricular hypertrophy, or; pulmonary hypertension (shown by Echo or cardiac catheterization), or; episode(s) of acute respiratory failure, or; requires outpatient oxygen therapy
BronchiectasisWith incapacitating episodes of infection of at least six weeks total duration per year
Asthma, bronchialFEV–1 less than 40-percent predicted, or; FEV–1/FVC less than 40 percent, or; more than one attack per week with episodes of respiratory failure, or; requires daily use of systemic (oral or parenteral) high dose corticosteroids or immuno-suppressive medications
Emphysema, pulmonaryFEV–1 less than 40 percent of predicted value, or; the ratio of Forced Expiratory Volume in one second to Forced Vital Capacity (FEV–1/FVC) less than 40 percent, or; Diffusion Capacity of the Lung for Carbon Monoxide by the Single Breath Method (DLCO (SB)) less than 40-percent predicted, or; maximum exercise capacity less than 15 ml/kg/min oxygen consumption (with cardiac or respiratory limitation), or; cor pulmonale (right heart failure), or; right ventricular hypertrophy, or; pulmonary hypertension (shown by Echo or cardiac catheterization), or; episode(s) of acute respiratory failure, or; requires outpatient oxygen therapy.
Chronic obstructive pulmonary diseaseFEV–1 less than 40 percent of predicted value, or; the ratio of Forced Expiratory Volume in one second to Forced Vital Capacity (FEV–1/FVC) less than 40 percent, or; Diffusion Capacity of the Lung for Carbon Monoxide by the Single Breath Method (DLCO (SB)) less than 40-percent predicted, or; maximum exercise capacity less than 15 ml/kg/min oxygen consumption (with cardiac or respiratory limitation), or; cor pulmonale (right heart failure), or; right ventricular hypertrophy, or; pulmonary hypertension (shown by Echo or cardiac catheterization), or; episode(s) of acute respiratory failure, or; requires outpatient oxygen therapy.
Tuberculosis, pulmonary, chronic, far advanced, active (entitled on August 19, 1968)N/A
Tuberculosis, pulmonary, chronic, moderately advanced, active  (entitled on August 19, 1968)N/A
Tuberculosis, pulmonary, chronic, minimal, active (entitled on August 19, 1968)N/A
Tuberculosis, pulmonary, chronic, active, advancement unspecified (entitled on August 19, 1968)N/A
Tuberculosis, pulmonary, chronic, far advanced, inactive (entitled on August 19, 1968)For two years after date of inactivity, following active tuberculosis, which was clinically identified during service or subsequently
Tuberculosis, pulmonary, chronic, moderately advanced, inactive (entitled on August 19, 1968)For two years after date of inactivity, following active tuberculosis, which was clinically identified during service or subsequently
Tuberculosis, pulmonary, chronic, minimal, inactive (entitled on August 19, 1968)For two years after date of inactivity, following active tuberculosis, which was clinically identified during service or subsequently
Tuberculosis, pulmonary, chronic, inactive, advancement unspecified (entitled on August 19, 1968)For two years after date of inactivity, following active tuberculosis, which was clinically identified during service or subsequently
Tuberculosis, pulmonary, chronic, active (entitled after August 19, 1968)N/A
Tuberculosis, pulmonary, chronic, inactive1 year after date of inactivity, following active tuberculosis
Pleurisy, tuberculous, active or inactiveIf Inactive:
Tuberculosis in effect on August 19,1968 – 2 years after date of inactivity, following active tuberculosis, which was clinically identified during service or subsequently
Tuberculosis in effect after August 19, 1968 – 1 year after date of inactivity, following active tuberculosis
Pulmonary Vascular DiseasePrimary pulmonary hypertension, or; chronic pulmonary thromboembolism with evidence of pulmonary hypertension, right ventricular hypertrophy, or cor pulmonale, or; pulmonary hypertension secondary to other obstructive disease of pulmonary arteries or veins with evidence of right ventricular hypertrophy or cor pulmonale
Neoplasms, malignant, any specified part of respiratory system exclusive of skin growths100 percent shall continue beyond the cessation of any surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination
Actinomycosis, ActiveActive infection with systemic symptoms such as fever, night sweats, weight loss, or hemoptysis
Nocardiosis, ActiveActive infection with systemic symptoms such as fever, night sweats, weight loss, or hemoptysis
Chronic lung abscess, ActiveActive infection with systemic symptoms such as fever, night sweats, weight loss, or hemoptysis
Interstitial Lung DiseaseForced Vital Capacity (FVC) less than 50-percent predicted, or; Diffusion Capacity of the Lung for Carbon Monoxide by the Single Breath Method (DLCO (SB)) less than 40-percent predicted, or; maximum exercise capacity less than 15 ml/kg/min oxygen consumption with cardiorespiratory limitation, or; cor pulmonale or pulmonary hypertension, or; requires outpatient oxygen therapy
Mycotic Lung DiseaseForced Vital Capacity (FVC) less than 50-percent predicted, or; Diffusion Capacity of the Lung for Carbon Monoxide by the Single Breath Method (DLCO (SB)) less than 40-percent predicted, or; maximum exercise capacity less than 15 ml/kg/min oxygen consumption with cardiorespiratory limitation, or; cor pulmonale or pulmonary hypertension, or; requires outpatient oxygen therapy
Interstitial Lung Disease-Diffuse interstitial fibrosis (interstitial pneumonitis, fibrosing alveolitis)Forced Vital Capacity (FVC) less than 50-percent predicted, or; Diffusion Capacity of the Lung for Carbon Monoxide by the Single Breath Method (DLCO (SB)) less than 40-percent predicted, or; maximum exercise capacity less than 15 ml/kg/min oxygen consumption with cardiorespiratory limitation, or; cor pulmonale or pulmonary hypertension, or; requires outpatient oxygen therapy
Interstitial Lung Disease-Desquamative interstitial pneumonitisForced Vital Capacity (FVC) less than 50-percent predicted, or; Diffusion Capacity of the Lung for Carbon Monoxide by the Single Breath Method (DLCO (SB)) less than 40-percent predicted, or; maximum exercise capacity less than 15 ml/kg/min oxygen consumption with cardiorespiratory limitation, or; cor pulmonale or pulmonary hypertension, or; requires outpatient oxygen therapy
Interstitial Lung Disease-Pulmonary alveolar proteinosisForced Vital Capacity (FVC) less than 50-percent predicted, or; Diffusion Capacity of the Lung for Carbon Monoxide by the Single Breath Method (DLCO (SB)) less than 40-percent predicted, or; maximum exercise capacity less than 15 ml/kg/min oxygen consumption with cardiorespiratory limitation, or; cor pulmonale or pulmonary hypertension, or; requires outpatient oxygen therapy
Interstitial Lung Disease-Eosinophilic granuloma of lungForced Vital Capacity (FVC) less than 50-percent predicted, or; Diffusion Capacity of the Lung for Carbon Monoxide by the Single Breath Method (DLCO (SB)) less than 40-percent predicted, or; maximum exercise capacity less than 15 ml/kg/min oxygen consumption with cardiorespiratory limitation, or; cor pulmonale or pulmonary hypertension, or; requires outpatient oxygen therapy
Interstitial Lung Disease-Drug-induced pulmonary pneumonitis and fibrosisForced Vital Capacity (FVC) less than 50-percent predicted, or; Diffusion Capacity of the Lung for Carbon Monoxide by the Single Breath Method (DLCO (SB)) less than 40-percent predicted, or; maximum exercise capacity less than 15 ml/kg/min oxygen consumption with cardiorespiratory limitation, or; cor pulmonale or pulmonary hypertension, or; requires outpatient oxygen therapy
Interstitial Lung Disease-Radiation-induced pulmonary pneumonitis and fibrosis.Forced Vital Capacity (FVC) less than 50-percent predicted, or; Diffusion Capacity of the Lung for Carbon Monoxide by the Single Breath Method (DLCO (SB)) less than 40-percent predicted, or; maximum exercise capacity less than 15 ml/kg/min oxygen consumption with cardiorespiratory limitation, or; cor pulmonale or pulmonary hypertension, or; requires outpatient oxygen therapy
Interstitial Lung Disease-Hypersensitivity pneumonitis (extrinsic allergic alveolitis)Forced Vital Capacity (FVC) less than 50-percent predicted, or; Diffusion Capacity of the Lung for Carbon Monoxide by the Single Breath Method (DLCO (SB)) less than 40-percent predicted, or; maximum exercise capacity less than 15 ml/kg/min oxygen consumption with cardiorespiratory limitation, or; cor pulmonale or pulmonary hypertension, or; requires outpatient oxygen therapy
Interstitial Lung Disease-Pneumoconiosis (silicosis, anthracosis, etc.)Forced Vital Capacity (FVC) less than 50-percent predicted, or; Diffusion Capacity of the Lung for Carbon Monoxide by the Single Breath Method (DLCO (SB)) less than 40-percent predicted, or; maximum exercise capacity less than 15 ml/kg/min oxygen consumption with cardiorespiratory limitation, or; cor pulmonale or pulmonary hypertension, or; requires outpatient oxygen therapy
Interstitial Lung Disease-AsbestosisForced Vital Capacity (FVC) less than 50-percent predicted, or; Diffusion Capacity of the Lung for Carbon Monoxide by the Single Breath Method (DLCO (SB)) less than 40-percent predicted, or; maximum exercise capacity less than 15 ml/kg/min oxygen consumption with cardiorespiratory limitation, or; cor pulmonale or pulmonary hypertension, or; requires outpatient oxygen therapy
Mycotic Lung Disease-Histoplasmosis of lungChronic pulmonary mycosis with persistent fever, weight loss, night sweats, or massive hemoptysis
Mycotic Lung Disease-CoccidioidomycosisChronic pulmonary mycosis with persistent fever, weight loss, night sweats, or massive hemoptysis
Mycotic Lung Disease-BlastomycosisChronic pulmonary mycosis with persistent fever, weight loss, night sweats, or massive hemoptysis
Mycotic Lung Disease-CryptococcosisChronic pulmonary mycosis with persistent fever, weight loss, night sweats, or massive hemoptysis
Mycotic Lung Disease-AspergillosisChronic pulmonary mycosis with persistent fever, weight loss, night sweats, or massive hemoptysis
Mycotic Lung Disease-MucormycosisChronic pulmonary mycosis with persistent fever, weight loss, night sweats, or massive hemoptysis
Restrictive Lung Disease-Diaphragm paralysis or paresisFEV–1 less than 40 percent of predicted value, or; the ratio of Forced Expiratory Volume in one second to Forced Vital Capacity (FEV–1/FVC) less than 40 percent, or; Diffusion Capacity of the Lung for Carbon Monoxide by the Single Breath Method (DLCO (SB)) less than 40-percent predicted, or; maximum exercise capacity less than 15 ml/kg/min oxygen consumption (with cardiac or respiratory limitation), or; cor pulmonale (right heart failure), or; right ventricular hypertrophy, or; pulmonary hypertension (shown by Echo or cardiac catheterization), or; episode(s) of acute respiratory failure, or; requires outpatient oxygen therapy
Restrictive Lung Disease-Spinal cord injury with respiratory insufficiencyFEV–1 less than 40 percent of predicted value, or; the ratio of Forced Expiratory Volume in one second to Forced Vital Capacity (FEV–1/FVC) less than 40 percent, or; Diffusion Capacity of the Lung for Carbon Monoxide by the Single Breath Method (DLCO (SB)) less than 40-percent predicted, or; maximum exercise capacity less than 15 ml/kg/min oxygen consumption (with cardiac or respiratory limitation), or; cor pulmonale (right heart failure), or; right ventricular hypertrophy, or; pulmonary hypertension (shown by Echo or cardiac catheterization), or; episode(s) of acute respiratory failure, or; requires outpatient oxygen therapy
Restrictive Lung Disease-Kyphoscoliosis, pectus excavatum, pectus carinatumFEV–1 less than 40 percent of predicted value, or; the ratio of Forced Expiratory Volume in one second to Forced Vital Capacity (FEV–1/FVC) less than 40 percent, or; Diffusion Capacity of the Lung for Carbon Monoxide by the Single Breath Method (DLCO (SB)) less than 40-percent predicted, or; maximum exercise capacity less than 15 ml/kg/min oxygen consumption (with cardiac or respiratory limitation), or; cor pulmonale (right heart failure), or; right ventricular hypertrophy, or; pulmonary hypertension (shown by Echo or cardiac catheterization), or; episode(s) of acute respiratory failure, or; requires outpatient oxygen therapy
Restrictive Lung Disease-Traumatic chest wall defect, pneumothorax, hernia, etcFEV–1 less than 40 percent of predicted value, or; the ratio of Forced Expiratory Volume in one second to Forced Vital Capacity (FEV–1/FVC) less than 40 percent, or; Diffusion Capacity of the Lung for Carbon Monoxide by the Single Breath Method (DLCO (SB)) less than 40-percent predicted, or; maximum exercise capacity less than 15 ml/kg/min oxygen consumption (with cardiac or respiratory limitation), or; cor pulmonale (right heart failure), or; right ventricular hypertrophy, or; pulmonary hypertension (shown by Echo or cardiac catheterization), or; episode(s) of acute respiratory failure, or; requires outpatient oxygen therapy
Restrictive Lung Disease-Post-surgical residual (lobectomy, pneumonectomy, etc.)FEV–1 less than 40 percent of predicted value, or; the ratio of Forced Expiratory Volume in one second to Forced Vital Capacity (FEV–1/FVC) less than 40 percent, or; Diffusion Capacity of the Lung for Carbon Monoxide by the Single Breath Method (DLCO (SB)) less than 40-percent predicted, or; maximum exercise capacity less than 15 ml/kg/min oxygen consumption (with cardiac or respiratory limitation), or; cor pulmonale (right heart failure), or; right ventricular hypertrophy, or; pulmonary hypertension (shown by Echo or cardiac catheterization), or; episode(s) of acute respiratory failure, or; requires outpatient oxygen therapy
Restrictive Lung Disease-Chronic pleural effusion or fibrosisFEV–1 less than 40 percent of predicted value, or; the ratio of Forced Expiratory Volume in one second to Forced Vital Capacity (FEV–1/FVC) less than 40 percent, or; Diffusion Capacity of the Lung for Carbon Monoxide by the Single Breath Method (DLCO (SB)) less than 40-percent predicted, or; maximum exercise capacity less than 15 ml/kg/min oxygen consumption (with cardiac or respiratory limitation), or; cor pulmonale (right heart failure), or; right ventricular hypertrophy, or; pulmonary hypertension (shown by Echo or cardiac catheterization), or; episode(s) of acute respiratory failure, or; requires outpatient oxygen therapy
Restrictive Lung Disease-SarcoidosisCor pulmonale, or; cardiac involvement with congestive heart failure, or; progressive pulmonary disease with fever, night sweats, and weight loss despite treatment
Restrictive Lung Disease-Sleep Apnea Syndromes (Obstructive, Central, Mixed)Chronic respiratory failure with carbon dioxide retention or cor pulmonale, or; requires tracheostomy
HeartValvular heart disease (including rheumatic heart disease)During active infection with cardiac involvement and for three months following cessation of therapy for the active infection
Endocarditis, orDuring active infection with cardiac involvement and for three months following cessation of therapy for the active infection
PericarditisDuring active infection with cardiac involvement and for three months following cessation of therapy for the active infection
Pericardial adhesionsWorkload of 3.0 METs or less results in heart failure symptoms
Syphilitic heart diseaseWorkload of 3.0 METs or less results in heart failure symptoms
Arteriosclerotic heart disease (coronary artery disease, Atherosclerotic heart disease, Ischemic heart disease)Workload of 3.0 METs or less results in heart failure symptoms
Myocardial infarctionDuring and for three months following myocardial infarction, confirmed by laboratory tests
Hypertensive heart diseaseWorkload of 3.0 METs or less results in heart failure symptoms
Hyperthyroid heart diseaseWorkload of 3.0 METs or less results in heart failure symptoms
Bradycardia (Bradyarrhythmia), symptomatic, requiring permanent pacemaker implantation:For one month following hospital discharge for implantation or re-implantation
Ventricular arrhythmias (sustained)For an indefinite period from the date of inpatient hospital admission for initial medical therapy for a sustained ventricular arrhythmia; or, for an indefinite period from the date of inpatient hospital admission for ventricular aneurysmectomy; or, with an automatic implantable cardioverter-defibrillator (AICD) in place. 100-percent evaluation begins on the date of hospital admission with a mandatory VA examination six months following hospital discharge.
Atrioventricular blockBenign (First-Degree and Second-Degree, Type I):
Workload of 3.0 METs or less results in heart failure symptoms

Non-Benign (Second-Degree, Type II and Third-Degree):
For one month following hospital discharge for implantation or re-implantation
Heart valve replacement (prosthesis)For an indefinite period following date of hospital admission for valve replacement
Coronary bypass surgeryFor three months following hospital admission for surgery
Implantable cardiac pacemakersFor one month following hospital discharge for implantation or re-implantation
Cardiac transplantationFor a minimum of one year from the date of hospital admission for cardiac transplantation
CardiomyopathyWorkload of 3.0 METs or less results in heart failure symptoms
Aortic aneurysm: Ascending, thoracic, or abdominalEvaluate at 100 percent if the aneurysm is any one of the following: Five centimeters or larger in diameter; symptomatic (e.g., precludes exertion); or requires surgery
Aneurysm, any large arteryIf symptomatic; or, for the period beginning on the date a physician recommends surgical correction and continuing for six months following discharge from inpatient hospital admission for surgical correction
Arteriovenous fistula, traumaticWith high-output heart failure
Peripheral arterial diseaseAt least one of the following: Ankle/brachial index less than or equal to 0.39; ankle pressure less than 50 mm Hg; toe pressure less than 30 mm Hg; or transcutaneous oxygen tension less than 30 mm Hg
Thrombo-angiitis obliterans (Buerger’s Disease)Lower extremity: Rate under Peripheral arterial disease
Upper extremity: Deep ischemic ulcers and necrosis of the fingers with persistent coldness of the extremity, trophic changes with pains in the hand during physical activity, and diminished upper extremity pulses
Raynaud’s syndrome (also known as secondary Raynaud’s phenomenon or secondary Raynaud’s)With two or more digital ulcers plus auto-amputation of one or more digits and history of characteristic attacks
ErythromelalgiaCharacteristic attacks that occur more than once a day, last an average of more than two hours each, respond poorly to treatment, and that restrict most routine daily activities
Varicose veinsMassive board-like edema with constant pain at rest
Post-phlebitic syndrome of any etiologyMassive board-like edema with constant pain at rest
Soft tissue sarcoma (of vascular origin)A rating of 100 percent shall continue beyond the cessation of any surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination
DigestiveTongue, loss of whole or partWith inability to communicate by speech
Ulcer, marginal (gastrojejunal)Pronounced; periodic or continuous pain unrelieved by standard ulcer therapy with periodic vomiting, recurring melena or hematemesis, and weight loss. Totally incapacitating
Cirrhosis of the liver, primary biliary cirrhosis, or cirrhotic phase of sclerosing cholangitisGeneralized weakness, substantial weight loss, and persistent jaundice, or; with one of the following refractory to treatment: ascites, hepatic encephalopathy, hemorrhage from varices or portal gastropathy (erosive gastritis)
Dysentery, bacillaryPronounced; resulting in marked malnutrition, anemia, and general debility, or with serious complication as liver abscess
Colitis, ulcerativePronounced; resulting in marked malnutrition, anemia, and general debility, or with serious complication as liver abscess
Intestine, fistula of, persistent, or after attempt at operative closureCopious and frequent, fecal discharge
Peritonitis, tuberculous, active or inactiveIf Inactive:
Tuberculosis in effect on August 19,1968 – 2 years after date of inactivity, following active tuberculosis, which was clinically identified during service or subsequently
Tuberculosis in effect after August 19, 1968 – 1 year after date of inactivity, following active tuberculosis
Rectum and anus, impairment of sphincter control:Complete loss of sphincter control
Rectum and anus, stricture ofRequiring colostomy
Ano, fistula inComplete loss of sphincter control
Hernia, ventral, postoperativeMassive, persistent, severe diastasis of recti muscles or extensive diffuse destruction or weakening of muscular and fascial support of abdominal wall so as to be inoperable
Malignant neoplasms of the digestive system, exclusive of skin growthsA rating of 100 percent shall continue beyond the cessation of any surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination.
Chronic liver disease without cirrhosis (including hepatitis B, chronic active hepatitis, autoimmune hepatitis, hemochromatosis, drug-induced hepatitis, etc., but excluding bile duct disorders and hepatitis C)Near-constant debilitating symptoms (such as fatigue, malaise, nausea, vomiting, anorexia, arthralgia, and right upper quadrant pain)
PancreatitisWith frequently recurrent disabling attacks of abdominal pain with few pain free intermissions and with steatorrhea, malabsorption, diarrhea and severe malnutrition
Liver transplantFor an indefinite period from the date of hospital admission for transplant surgery. 100 percent shall be assigned as of the date of hospital admission for transplant surgery and shall continue. One year following discharge, the appropriate disability rating shall be determined by mandatory VA examination.
Hepatitis C (or non-A, non-B hepatitis)With serologic evidence of hepatitis C infection with near-constant debilitating symptoms (such as fatigue, malaise, nausea, vomiting, anorexia, arthralgia, and right upper quadrant pain)
GenitourinaryKidney, removal of oneIf there is renal dysfunction: Chronic kidney disease with glomerular filtration rate (GFR) less than 15 mL/min/1.73 m2 for at least 3 consecutive months during the past 12 months; or requiring regular routine dialysis; or eligible kidney transplant recipient
Nephritis, chronicChronic kidney disease with glomerular filtration rate (GFR) less than 15 mL/min/1.73 m2 for at least 3 consecutive months during the past 12 months; or requiring regular routine dialysis; or eligible kidney transplant recipient
Pyelonephritis, chronicChronic kidney disease with glomerular filtration rate (GFR) less than 15 mL/min/1.73 m2 for at least 3 consecutive months during the past 12 months; or requiring regular routine dialysis; or eligible kidney transplant recipient
Kidney, tuberculosis ofIf Inactive:
Tuberculosis in effect on August 19,1968 – 2 years after date of inactivity, following active tuberculosis, which was clinically identified during service or subsequently
Tuberculosis in effect after August 19, 1968 – 1 year after date of inactivity, following active tuberculosis
Nephrosclerosis, arteriolarChronic kidney disease with glomerular filtration rate (GFR) less than 15 mL/min/1.73 m2 for at least 3 consecutive months during the past 12 months; or requiring regular routine dialysis; or eligible kidney transplant recipient
HydronephrosisIf severe, rate as renal dysfunction. Chronic kidney disease with glomerular filtration rate (GFR) less than 15 mL/min/1.73 m2 for at least 3 consecutive months during the past 12 months; or requiring regular routine dialysis; or eligible kidney transplant recipient
Bladder, fistula of:Postoperative, suprapubic cystotomy
Urethra, fistula ofMultiple urethroperineal fistulae
Malignant neoplasms of the genitourinary systemFollowing the cessation of surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure, the rating of 100 percent shall continue with a mandatory VA examination at the expiration of six months.
Chronic renal disease requiring regular dialysisChronic kidney disease with glomerular filtration rate (GFR) less than 15 mL/min/1.73 m2 for at least 3 consecutive months during the past 12 months; or requiring regular routine dialysis; or eligible kidney transplant recipient
Kidney transplantFollowing transplant surgery. 100 percent evaluation shall be assigned as of the date of hospital admission for transplant surgery and shall continue with a mandatory VA examination one year following hospital discharge.
Renal tubular disorders (such as renal glycosurias, aminoacidurias, renal tubular acidosis, Fanconi’s syndrome, Bartter’s syndrome, related disorders of Henle’s loop and proximal or distal nephron function, etc.):Can be rated as renal dysfunction. Chronic kidney disease with glomerular filtration rate (GFR) less than 15 mL/min/1.73 m2 for at least 3 consecutive months during the past 12 months; or requiring regular routine dialysis; or eligible kidney transplant recipient
Cystic diseases of the kidneysChronic kidney disease with glomerular filtration rate (GFR) less than 15 mL/min/1.73 m2 for at least 3 consecutive months during the past 12 months; or requiring regular routine dialysis; or eligible kidney transplant recipient
Atherosclerotic renal disease (renal artery stenosis, atheroembolic renal disease, or large vessel disease, unspecified):Chronic kidney disease with glomerular filtration rate (GFR) less than 15 mL/min/1.73 m2 for at least 3 consecutive months during the past 12 months; or requiring regular routine dialysis; or eligible kidney transplant recipient
Toxic nephropathy (antibotics, radiocontrast agents, nonsteroidal anti-inflammatory agents, heavy metals, and similar agents)Chronic kidney disease with glomerular filtration rate (GFR) less than 15 mL/min/1.73 m2 for at least 3 consecutive months during the past 12 months; or requiring regular routine dialysis; or eligible kidney transplant recipient
GlomerulonephritisChronic kidney disease with glomerular filtration rate (GFR) less than 15 mL/min/1.73 m2 for at least 3 consecutive months during the past 12 months; or requiring regular routine dialysis; or eligible kidney transplant recipient
Interstitial nephritis, including gouty nephropathy, disorders of calcium metabolismChronic kidney disease with glomerular filtration rate (GFR) less than 15 mL/min/1.73 m2 for at least 3 consecutive months during the past 12 months; or requiring regular routine dialysis; or eligible kidney transplant recipient
Papillary necrosisChronic kidney disease with glomerular filtration rate (GFR) less than 15 mL/min/1.73 m2 for at least 3 consecutive months during the past 12 months; or requiring regular routine dialysis; or eligible kidney transplant recipient
Renal amyloid diseaseChronic kidney disease with glomerular filtration rate (GFR) less than 15 mL/min/1.73 m2 for at least 3 consecutive months during the past 12 months; or requiring regular routine dialysis; or eligible kidney transplant recipient
Disseminated intravascular coagulation with renal cortical necrosisChronic kidney disease with glomerular filtration rate (GFR) less than 15 mL/min/1.73 m2 for at least 3 consecutive months during the past 12 months; or requiring regular routine dialysis; or eligible kidney transplant recipient
Renal involvement in diabetes mellitus type I or IIChronic kidney disease with glomerular filtration rate (GFR) less than 15 mL/min/1.73 m2 for at least 3 consecutive months during the past 12 months; or requiring regular routine dialysis; or eligible kidney transplant recipient
Renal disease caused by viral infection such as human immunodeficiency virus (HIV), Hepatitis B, and Hepatitis CChronic kidney disease with glomerular filtration rate (GFR) less than 15 mL/min/1.73 m2 for at least 3 consecutive months during the past 12 months; or requiring regular routine dialysis; or eligible kidney transplant recipient
GynecologicalUterus and both ovaries, removal of, completeFor three months after removal
Uterus, removal of, including corpusFor three months after removal
Ovary, removal ofFor three months after removal
Fistula, rectovaginalVaginal fecal leakage at least once a day requiring wearing of pad
Fistula, urethrovaginalMultiple urethrovaginal fistulae
Malignant neoplasms of gynecological system100 percent shall continue beyond the cessation of any surgical, radiation, antineoplastic chemotherapy or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination.
Malignant neoplasms of the breast100 percent shall continue beyond the cessation of any surgical, radiation, antineoplastic chemotherapy or other therapeutic procedure. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination.
Hemic and lymphaticAgranulocytosis, acquiredRequiring bone marrow transplant; or infections recurring, on average, at least once every six weeks per 12-month period
Leukemia (except for chronic myelogenous leukemia)When there is active disease or during a treatment phase. A 100 percent evaluation shall continue beyond the cessation of any surgical therapy, radiation therapy, antineoplastic chemotherapy, or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination.
Polycythemia veraRequiring peripheral blood or bone marrow stem-cell transplant or chemotherapy (including myelosuppressants) for the purpose of ameliorating the symptom burden. A 100 percent evaluation shall be assigned as of the date of hospital admission for peripheral blood or bone marrow stem cell transplant; or during the period of treatment with chemotherapy (including myelosuppressants). Six months following hospital discharge or, in the case of chemotherapy treatment, six months after completion of treatment, the appropriate disability rating shall be determined by mandatory VA examination.
Immune thrombocytopeniaRequiring chemotherapy for chronic refractory thrombocytopenia; or a platelet count 30,000 or below despite treatment. 100 percent evaluation shall continue beyond the cessation of chemotherapy. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination.
Hodgkin’s lymphomaWith active disease or during a treatment phase. 100 percent evaluation shall continue beyond the cessation of any surgical therapy, radiation therapy, antineoplastic chemotherapy, or other therapeutic procedures. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination.
Adenitis, tuberculous, active or inactiveIf Inactive:
Tuberculosis in effect on August 19,1968 – 2 years after date of inactivity, following active tuberculosis, which was clinically identified during service or subsequently
Tuberculosis in effect after August 19, 1968 – 1 year after date of inactivity, following active tuberculosis
Multiple myelomaSymptomatic multiple myeloma. 100 percent evaluation shall continue for five years after the diagnosis of symptomatic multiple myeloma, at which time the appropriate disability evaluation shall be determined by mandatory VA examination.
Sickle cell anemiaWith at least 4 or more painful episodes per 12-month period, occurring in skin, joints, bones, or any major organs, caused by hemolysis and sickling of red blood cells, with anemia, thrombosis, and infarction, with residual symptoms precluding even light manual labor
Non-Hodgkin’s lymphomaWhen there is active disease, during treatment phase, or with indolent and non-contiguous phase of low grade NHL. 100 percent evaluation shall continue beyond the cessation of any surgical therapy, radiation therapy, antineoplastic chemotherapy, or other therapeutic procedures. Two years after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination.
Aplastic anemiaRequiring peripheral blood or bone marrow stem cell transplant; or requiring transfusion of platelets or red cells, on average, at least once every six weeks per 12-month period; or infections recurring, on average, at least once every six weeks per 12-month period.
AL amyloidosis (primary amyloidosis)N/A
Essential thrombocythemia and primary myelofibrosisRequiring either continuous myelosuppressive therapy, or, for six months following hospital admission for any of the following treatments: peripheral blood or bone marrow stem cell transplant, or chemotherapy, or interferon treatment
Chronic myelogenous leukemia (CML) (chronic myeloid leukemia or chronic granulocytic leukemia)Requiring peripheral blood or bone marrow stem cell transplant, or continuous myelosuppressive or immunosuppressive therapy treatment. 100 percent evaluation shall be assigned as of the date of hospital admission for peripheral blood or bone marrow stem cell transplant; or during the period of treatment with chemotherapy (including myelosuppressants). Six months following hospital discharge or, in the case of chemotherapy treatment, six months after completion of treatment, the appropriate disability rating shall be determined by mandatory VA examination.
Pernicious anemia and Vitamin B12 deficiency anemiaFor initial diagnosis requiring transfusion due to severe anemia, or if there are signs or symptoms related to central nervous system impairment, such as encephalopathy, myelopathy, or severe peripheral neuropathy, requiring parenteral B12 therapy. 100 percent evaluation for pernicious anemia and Vitamin B12 deficiency shall be assigned as of the date of the initial diagnosis requiring transfusion due to severe anemia or parenteral B12 therapy and shall continue with a mandatory VA examination six months following hospital discharge or cessation of parenteral B12 therapy.
Acquired hemolytic anemiaRequiring a bone marrow transplant or continuous intravenous or immunosuppressive therapy (e.g., prednisone, Cytoxan, azathioprine, or rituximab). 100 percent evaluation for bone marrow transplant shall be assigned as of the date of hospital admission and shall continue for six months after hospital discharge with a mandatory VA examination six months following hospital discharge.
Solitary plasmacytomaSolitary plasmacytoma, when there is active disease or during a treatment phase. 100 percent evaluation shall continue beyond the cessation of any surgical therapy, radiation therapy, antineoplastic chemotherapy, or other therapeutic procedures (including autologous stem cell transplantation). Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination.
Myelodysplastic syndromesRequiring peripheral blood or bone marrow stem cell transplant; or requiring chemotherapy. 100 percent evaluation shall be assigned as of the date of hospital admission for peripheral blood or bone marrow stem cell transplant, or during the period of treatment with chemotherapy, and shall continue with a mandatory VA examination six months following hospital discharge or, in the case of chemotherapy treatment, six months after completion of treatment.
SkinErythrodermaGeneralized involvement of the skin with systemic manifestations (such as fever, weight loss, or hypoproteinemia) AND one of the following:

Constant or near-constant systemic therapy such as therapeutic doses of corticosteroids, other immunosuppressive drugs, retinoids, PUVA (psoralen with long-wave ultraviolet-A light), UVB (ultraviolet-B light) treatments, biologics, or electron beam therapy required over the past 12 month period; or

No current treatment due to a documented history of treatment failure with 2 or more treatment regimens
Malignant skin neoplasms (other than malignant melanoma)If a skin malignancy requires therapy that is comparable to that used for systemic malignancies, i.e., systemic chemotherapy, X-ray therapy more extensive than to the skin, or surgery more extensive than wide local excision, a 100-percent evaluation will be assigned from the date of onset of treatment, and will continue, with a mandatory VA examination six months following the completion of such antineoplastic treatment.
EndocrineHypothyroidismHypothyroidism manifesting as myxedema (cold intolerance, muscular weakness, cardiovascular involvement (including, but not limited to hypotension, bradycardia, and pericardial effusion), and mental disturbance (including, but not limited to dementia, slowing of thought and depression)). This evaluation shall continue for six months beyond the date that an examining physician has determined crisis stabilization.
HyperparathyroidismFor six months from date of discharge following surgery
HypoparathyroidismFor three months after initial diagnosis
Cushing’s syndromeAs active, progressive disease, including areas of osteoporosis, hypertension, and proximal upper and lower extremity muscle wasting that results in inability to rise from squatting position, climb stairs, rise from a deep chair without assistance, or raise arms. This shall continue for six months following initial diagnosis.
AcromegalyEvidence of increased intracranial pressure (such as visual field defect), arthropathy, glucose intolerance, and either hypertension or cardiomegaly
Polyglandular syndrome (multiple endocrine neoplasia, autoimmune polyglandular syndrome)Evaluate according to major manifestations to include, but not limited to, Type I diabetes mellitus, hyperthyroidism, hypothyroidism, hypoparathyroidism, or Addison’s disease.
Diabetes mellitusRequiring more than one daily injection of insulin, restricted diet, and regulation of activities (avoidance of strenuous occupational and recreational activities) with episodes of ketoacidosis or hypoglycemic reactions requiring at least three hospitalizations per year or weekly visits to a diabetic care provider, plus either progressive loss of weight and strength or complications that would be compensable if separately evaluated
Neoplasm, malignant, any specified part of the endocrine system100 percent shall continue beyond the cessation of any surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination.
Hyperpituitarism (prolactin secreting pituitary dysfunction)Evaluate as malignant or benign neoplasm, as appropriate.
Hyperaldosteronism (benign or malignant)Evaluate as malignant or benign neoplasm, as appropriate.
Pheochromocytoma (benign or malignant)Evaluate as malignant or benign neoplasm, as appropriate.
C-cell hyperplasia of the thyroidIf antineoplastic therapy is required, evaluate as a malignant neoplasm under DC 7914. If a prophylactic thyroidectomy is performed (based upon genetic testing) and antineoplastic therapy is not required, evaluate as hypothyroidism under DC 7903.
Neurological Conditions and Convulsive DisordersEncephalitis, epidemic, chronicAs active febrile disease
MalignantThe rating in code 8002 will be continued for 2 years following cessation of surgical, chemotherapeutic or other treatment modality. At this point, if the residuals have stabilized, the rating will be made on neurological residuals according to symptomatology.
Bulbar palsyN/A
Brain, vessels, embolism ofFor 6 months
Brain, vessels, thrombosis ofFor 6 months
Brain, vessels, hemorrhage fromFor 6 months
Poliomyelitis, anteriorAs active febrile disease
HematomyeliaFor 6 months
Amyotrophic lateral sclerosisN/A`
Meningitis, cerebrospinal, epidemicAs active febrile disease
Brain, abscess ofAs active disease
Chorea, Sydenham’sPronounced, progressive grave types
Chorea, Huntington’s.Pronounced, progressive grave types
Athetosis, acquiredPronounced, progressive grave types
Peripheral NervesSoft-tissue sarcoma (of neurogenic origin)The 100 percent rating will be continued for 6 months following the cessation of surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure. At this point, if there has been no local recurrence or metastases, the rating will be made on residuals.
EpilepsiesEpilepsy, grand malAveraging at least 1 major seizure per month over the last year
Epilepsy, petit malAveraging at least 1 major seizure per month over the last year
Epilepsy, Jacksonian and focal motor or sensoryAveraging at least 1 major seizure per month over the last year
Epilepsy, diencephalicAveraging at least 1 major seizure per month over the last year
Epilepsy, psychomotorAveraging at least 1 major seizure per month over the last year
Mental DisordersSchizophreniaTotal occupational and social impairment, due to such symptoms as: gross impairment in thought processes or communication; persistent delusions or hallucinations; grossly inappropriate behavior; persistent danger of hurting self or others; intermittent inability to perform activities of daily living (including maintenance of minimal personal hygiene); disorientation to time or place; memory loss for names of close relatives, own occupation, or own name.
Delusional disorderTotal occupational and social impairment, due to such symptoms as: gross impairment in thought processes or communication; persistent delusions or hallucinations; grossly inappropriate behavior; persistent danger of hurting self or others; intermittent inability to perform activities of daily living (including maintenance of minimal personal hygiene); disorientation to time or place; memory loss for names of close relatives, own occupation, or own name.
Other specified and unspecified schizophrenia spectrum and other psychotic disordersTotal occupational and social impairment, due to such symptoms as: gross impairment in thought processes or communication; persistent delusions or hallucinations; grossly inappropriate behavior; persistent danger of hurting self or others; intermittent inability to perform activities of daily living (including maintenance of minimal personal hygiene); disorientation to time or place; memory loss for names of close relatives, own occupation, or own name.
Schizoaffective disorderTotal occupational and social impairment, due to such symptoms as: gross impairment in thought processes or communication; persistent delusions or hallucinations; grossly inappropriate behavior; persistent danger of hurting self or others; intermittent inability to perform activities of daily living (including maintenance of minimal personal hygiene); disorientation to time or place; memory loss for names of close relatives, own occupation, or own name.
DeliriumTotal occupational and social impairment, due to such symptoms as: gross impairment in thought processes or communication; persistent delusions or hallucinations; grossly inappropriate behavior; persistent danger of hurting self or others; intermittent inability to perform activities of daily living (including maintenance of minimal personal hygiene); disorientation to time or place; memory loss for names of close relatives, own occupation, or own name.
Major or mild neurocognitive disorder due to HIV or other infections (Dementia)Total occupational and social impairment, due to such symptoms as: gross impairment in thought processes or communication; persistent delusions or hallucinations; grossly inappropriate behavior; persistent danger of hurting self or others; intermittent inability to perform activities of daily living (including maintenance of minimal personal hygiene); disorientation to time or place; memory loss for names of close relatives, own occupation, or own name.
Major or mild neurocognitive disorder due to traumatic brain injury (Dementia)Total occupational and social impairment, due to such symptoms as: gross impairment in thought processes or communication; persistent delusions or hallucinations; grossly inappropriate behavior; persistent danger of hurting self or others; intermittent inability to perform activities of daily living (including maintenance of minimal personal hygiene); disorientation to time or place; memory loss for names of close relatives, own occupation, or own name.
Major or mild vascular neurocognitive disorder (Dementia)Total occupational and social impairment, due to such symptoms as: gross impairment in thought processes or communication; persistent delusions or hallucinations; grossly inappropriate behavior; persistent danger of hurting self or others; intermittent inability to perform activities of daily living (including maintenance of minimal personal hygiene); disorientation to time or place; memory loss for names of close relatives, own occupation, or own name.
Unspecified neurocognitive disorder (Dementia)Total occupational and social impairment, due to such symptoms as: gross impairment in thought processes or communication; persistent delusions or hallucinations; grossly inappropriate behavior; persistent danger of hurting self or others; intermittent inability to perform activities of daily living (including maintenance of minimal personal hygiene); disorientation to time or place; memory loss for names of close relatives, own occupation, or own name.
Major or mild neurocognitive disorder due to Alzheimer’s diseaseTotal occupational and social impairment, due to such symptoms as: gross impairment in thought processes or communication; persistent delusions or hallucinations; grossly inappropriate behavior; persistent danger of hurting self or others; intermittent inability to perform activities of daily living (including maintenance of minimal personal hygiene); disorientation to time or place; memory loss for names of close relatives, own occupation, or own name.
Major or mild neurocognitive disorder due to another medical condition or substance/medication-induced major or mild neurocognitive disorderTotal occupational and social impairment, due to such symptoms as: gross impairment in thought processes or communication; persistent delusions or hallucinations; grossly inappropriate behavior; persistent danger of hurting self or others; intermittent inability to perform activities of daily living (including maintenance of minimal personal hygiene); disorientation to time or place; memory loss for names of close relatives, own occupation, or own name.
Generalized anxiety disorderTotal occupational and social impairment, due to such symptoms as: gross impairment in thought processes or communication; persistent delusions or hallucinations; grossly inappropriate behavior; persistent danger of hurting self or others; intermittent inability to perform activities of daily living (including maintenance of minimal personal hygiene); disorientation to time or place; memory loss for names of close relatives, own occupation, or own name.
Specific phobia; social anxiety disorder (social phobia)Total occupational and social impairment, due to such symptoms as: gross impairment in thought processes or communication; persistent delusions or hallucinations; grossly inappropriate behavior; persistent danger of hurting self or others; intermittent inability to perform activities of daily living (including maintenance of minimal personal hygiene); disorientation to time or place; memory loss for names of close relatives, own occupation, or own name.
Obsessive compulsive disorderTotal occupational and social impairment, due to such symptoms as: gross impairment in thought processes or communication; persistent delusions or hallucinations; grossly inappropriate behavior; persistent danger of hurting self or others; intermittent inability to perform activities of daily living (including maintenance of minimal personal hygiene); disorientation to time or place; memory loss for names of close relatives, own occupation, or own name.
Other specified anxiety disorderTotal occupational and social impairment, due to such symptoms as: gross impairment in thought processes or communication; persistent delusions or hallucinations; grossly inappropriate behavior; persistent danger of hurting self or others; intermittent inability to perform activities of daily living (including maintenance of minimal personal hygiene); disorientation to time or place; memory loss for names of close relatives, own occupation, or own name.
Posttraumatic stress disorderTotal occupational and social impairment, due to such symptoms as: gross impairment in thought processes or communication; persistent delusions or hallucinations; grossly inappropriate behavior; persistent danger of hurting self or others; intermittent inability to perform activities of daily living (including maintenance of minimal personal hygiene); disorientation to time or place; memory loss for names of close relatives, own occupation, or own name.
Panic disorder and/or agoraphobiaTotal occupational and social impairment, due to such symptoms as: gross impairment in thought processes or communication; persistent delusions or hallucinations; grossly inappropriate behavior; persistent danger of hurting self or others; intermittent inability to perform activities of daily living (including maintenance of minimal personal hygiene); disorientation to time or place; memory loss for names of close relatives, own occupation, or own name.
Unspecified anxiety disorderTotal occupational and social impairment, due to such symptoms as: gross impairment in thought processes or communication; persistent delusions or hallucinations; grossly inappropriate behavior; persistent danger of hurting self or others; intermittent inability to perform activities of daily living (including maintenance of minimal personal hygiene); disorientation to time or place; memory loss for names of close relatives, own occupation, or own name.
Dissociative amnesia; dissociative identity disorderTotal occupational and social impairment, due to such symptoms as: gross impairment in thought processes or communication; persistent delusions or hallucinations; grossly inappropriate behavior; persistent danger of hurting self or others; intermittent inability to perform activities of daily living (including maintenance of minimal personal hygiene); disorientation to time or place; memory loss for names of close relatives, own occupation, or own name.
Depersonalization/Derealization disorderTotal occupational and social impairment, due to such symptoms as: gross impairment in thought processes or communication; persistent delusions or hallucinations; grossly inappropriate behavior; persistent danger of hurting self or others; intermittent inability to perform activities of daily living (including maintenance of minimal personal hygiene); disorientation to time or place; memory loss for names of close relatives, own occupation, or own name.
Somatic symptom disorderTotal occupational and social impairment, due to such symptoms as: gross impairment in thought processes or communication; persistent delusions or hallucinations; grossly inappropriate behavior; persistent danger of hurting self or others; intermittent inability to perform activities of daily living (including maintenance of minimal personal hygiene); disorientation to time or place; memory loss for names of close relatives, own occupation, or own name.
Other specified somatic symptom and related disorderTotal occupational and social impairment, due to such symptoms as: gross impairment in thought processes or communication; persistent delusions or hallucinations; grossly inappropriate behavior; persistent danger of hurting self or others; intermittent inability to perform activities of daily living (including maintenance of minimal personal hygiene); disorientation to time or place; memory loss for names of close relatives, own occupation, or own name.
Unspecified somatic symptom and related disorderTotal occupational and social impairment, due to such symptoms as: gross impairment in thought processes or communication; persistent delusions or hallucinations; grossly inappropriate behavior; persistent danger of hurting self or others; intermittent inability to perform activities of daily living (including maintenance of minimal personal hygiene); disorientation to time or place; memory loss for names of close relatives, own occupation, or own name.
Conversion disorder (functional neurological symptom disorder)Total occupational and social impairment, due to such symptoms as: gross impairment in thought processes or communication; persistent delusions or hallucinations; grossly inappropriate behavior; persistent danger of hurting self or others; intermittent inability to perform activities of daily living (including maintenance of minimal personal hygiene); disorientation to time or place; memory loss for names of close relatives, own occupation, or own name.
Illness anxiety disorder (Hypochondriasis)Total occupational and social impairment, due to such symptoms as: gross impairment in thought processes or communication; persistent delusions or hallucinations; grossly inappropriate behavior; persistent danger of hurting self or others; intermittent inability to perform activities of daily living (including maintenance of minimal personal hygiene); disorientation to time or place; memory loss for names of close relatives, own occupation, or own name.
Cyclothymic disorderTotal occupational and social impairment, due to such symptoms as: gross impairment in thought processes or communication; persistent delusions or hallucinations; grossly inappropriate behavior; persistent danger of hurting self or others; intermittent inability to perform activities of daily living (including maintenance of minimal personal hygiene); disorientation to time or place; memory loss for names of close relatives, own occupation, or own name.
Bipolar disorderTotal occupational and social impairment, due to such symptoms as: gross impairment in thought processes or communication; persistent delusions or hallucinations; grossly inappropriate behavior; persistent danger of hurting self or others; intermittent inability to perform activities of daily living (including maintenance of minimal personal hygiene); disorientation to time or place; memory loss for names of close relatives, own occupation, or own name.
Persistent depressive disorder (dysthymia)Total occupational and social impairment, due to such symptoms as: gross impairment in thought processes or communication; persistent delusions or hallucinations; grossly inappropriate behavior; persistent danger of hurting self or others; intermittent inability to perform activities of daily living (including maintenance of minimal personal hygiene); disorientation to time or place; memory loss for names of close relatives, own occupation, or own name.
Major depressive disorderTotal occupational and social impairment, due to such symptoms as: gross impairment in thought processes or communication; persistent delusions or hallucinations; grossly inappropriate behavior; persistent danger of hurting self or others; intermittent inability to perform activities of daily living (including maintenance of minimal personal hygiene); disorientation to time or place; memory loss for names of close relatives, own occupation, or own name.
Unspecified depressive disorderTotal occupational and social impairment, due to such symptoms as: gross impairment in thought processes or communication; persistent delusions or hallucinations; grossly inappropriate behavior; persistent danger of hurting self or others; intermittent inability to perform activities of daily living (including maintenance of minimal personal hygiene); disorientation to time or place; memory loss for names of close relatives, own occupation, or own name.
Chronic adjustment disorderTotal occupational and social impairment, due to such symptoms as: gross impairment in thought processes or communication; persistent delusions or hallucinations; grossly inappropriate behavior; persistent danger of hurting self or others; intermittent inability to perform activities of daily living (including maintenance of minimal personal hygiene); disorientation to time or place; memory loss for names of close relatives, own occupation, or own name.
Anorexia nervosaSelf-induced weight loss to less than 80 percent of expected minimum weight, with incapacitating episodes of at least six weeks total duration per year, and requiring hospitalization more than twice a year for parenteral nutrition or tube feeding.
Bulimia nervosaSelf-induced weight loss to less than 80 percent of expected minimum weight, with incapacitating episodes of at least six weeks total duration per year, and requiring hospitalization more than twice a year for parenteral nutrition or tube feeding.
Dental and OralMaxilla or mandible, chronic osteomyelitis, osteonecrosis or osteoradionecrosis ofOf the pelvis, vertebrae, or extending into major joints, or with multiple localization or with long history of intractability and debility, anemia, amyloid liver changes, or other continuous constitutional symptoms
Mandible, loss of, complete, between anglesN/A
Maxilla, loss of more than halfNot replaceable by prosthesis
Neoplasm, hard and soft tissue, malignantA rating of 100 percent shall continue beyond the cessation of any surgical, radiation, antineoplastic chemotherapy or other therapeutic procedure. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination.

About the Author

Brian Reese
Brian Reese

Brian Reese

Brian Reese is a world-renowned VA disability benefits expert and the #1 bestselling author of VA Claim Secrets and You Deserve It. Motivated by his own frustration with the VA claim process, Brian founded VA Claims Insider to help disabled veterans secure their VA disability compensation faster, regardless of their past struggles with the VA. Since 2013, he has positively impacted the lives of over 10 million military, veterans, and their families.

A former active-duty Air Force officer, Brian has extensive experience leading diverse teams in challenging international environments, including a combat tour in Afghanistan in 2011 supporting Operation ENDURING FREEDOM.

Brian is a Distinguished Graduate of Management from the United States Air Force Academy and earned his MBA from Oklahoma State University’s Spears School of Business, where he was a National Honor Scholar, ranking in the top 1% of his class.

Related Articles

Elite Membership

Dear Veteran,
Here’s the brutal truth about VA disability claims:

According to our data, 8/10 (80%) of veterans reading this message right now are underrated by the VA…

This means you do NOT currently have the VA disability rating and compensation YOU deserve, and you could be missing out on thousands of dollars of tax-free compensation and benefits each month.

As a fellow disabled Veteran this is shameful and I’m on a mission to change it.

Brian Reese here, Air Force service-disabled Veteran and Founder @ VA Claims Insider.

Since 2016, VA Claims Insider has helped thousands of Veterans just like you get the VA rating and compensation they deserve in less time.

If accepted into our ELITE membership program, you’ll get free up-front access and permission to use $13,119 worth of proprietary VA claim resources, including access to our network of independent medical professionals for medical examinations, disability evaluations, and credible Medical Nexus Letters, which could help you get a HIGHER VA rating in LESS time.

It’s FREE to get started, so click “Go Elite Now” below to complete our 3-step intake process.

  1. Complete Basic Information
  2. Sign Members Agreement
  3. Join the Mastermind Group

If you’re stuck, frustrated, underrated, and currently rated between 0%-90%, VA Claims Insider Elite is for you!

Click “Go Elite Now” below to get started today and a member of our team will be in touch within minutes.

Go Elite Now!

Why Choose VA Claims Insider

You’ve exhausted your free resources

You're not alone. Thousands of other Veterans in our Community are here for you.

Veteran Community

You’re ready to get the rating you deserve

We know the pain of feeling stuck, frustrated, and alone, and we want to make this process as easy and painless as possible for you.

Explore Elite Membership

We win ONLY when YOU win

Hear from fellow Veterans just like you, with many of our Veteran Ambassadors having gone through our programs.

Schedule a Call

Fellow Veterans:

For a limited time, you can book a no-obligation VA Claim Discovery Call with one of our experts.

Book A Call

Fellow Veterans:

For a limited time, you can book a no-obligation VA Claim Discovery Call with one of our experts.

Book A Call